Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs Inovio Pharmaceuticals, Inc. (INO)

Foghorn Therapeutics Inc. and Inovio Pharmaceuticals, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and Inovio Pharmaceuticals, Inc. are of similar size ($112.2M and $107.5M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against −54.8%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Foghorn Therapeutics Inc. leads on 9 and Inovio Pharmaceuticals, Inc. on 5.

Valuation

Metric FHTX INO Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 209.44 9.71
P/B n/m 18.49 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 n/m 0.64
EV/Sales (0.46) 157.45 9.21
Earnings yield (52.97%) (91.92%) (33.15%)
Free cash flow yield (64.53%) (99.09%) (25.50%)

Profitability

Metric FHTX INO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% (409.87%) (56.36%)
Return on assets (30.06%) (114.64%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FHTX INO Biotechnology median
Revenue growth (TTM) 51.98% (54.82%) 6.02%
EPS growth (last fiscal year) 25.32% 54.18% 30.26%
Revenue growth, 5-year CAGR 135.14% (61.18%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX INO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 1.00 4.72
Net debt to EBITDA 1.88 0.70 0.96

Dividend

Metric FHTX INO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FHTX INO Biotechnology median
Market cap 112.24m 107.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack